Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Mallinckrodt
Harvard Business School
Baxter
AstraZeneca

Last Updated: May 26, 2022

CLINICAL TRIALS PROFILE FOR ACETIC ACID


✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for Acetic Acid

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00003697 ↗ Dimethylxanthenone Acetic Acid in Treating Patients With Solid Tumors Completed University of Glasgow Phase 1 1995-10-01 RATIONALE: Dimethylxanthenone acetic acid may stop the growth of cancer cells by stopping blood flow to the tumor. PURPOSE: Phase I trial to study the effectiveness of dimethylxanthenone acetic acid in treating patients with solid tumors that have not responded to previous therapy.
NCT00044213 ↗ Trial to Assess Chelation Therapy (TACT) Completed National Center for Complementary and Integrative Health (NCCIH) Phase 3 2003-09-01 The purpose of this study is to determine the safety and effectiveness of ethylene diamine tetra-acetic (EDTA) chelation therapy in individuals with coronary artery disease.
NCT00044213 ↗ Trial to Assess Chelation Therapy (TACT) Completed National Heart, Lung, and Blood Institute (NHLBI) Phase 3 2003-09-01 The purpose of this study is to determine the safety and effectiveness of ethylene diamine tetra-acetic (EDTA) chelation therapy in individuals with coronary artery disease.
NCT00044213 ↗ Trial to Assess Chelation Therapy (TACT) Completed Mt. Sinai Medical Center, Miami Phase 3 2003-09-01 The purpose of this study is to determine the safety and effectiveness of ethylene diamine tetra-acetic (EDTA) chelation therapy in individuals with coronary artery disease.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Acetic Acid

Condition Name

Condition Name for Acetic Acid
Intervention Trials
Unspecified Adult Solid Tumor, Protocol Specific 3
Cervical Cancer 3
Hepatic Encephalopathy 2
Skin Fibrosis 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Acetic Acid
Intervention Trials
Neoplasms 5
Uterine Cervical Neoplasms 4
Diabetes Mellitus 4
Carcinoma 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Acetic Acid

Trials by Country

Trials by Country for Acetic Acid
Location Trials
United States 51
Egypt 9
Canada 8
Italy 7
United Kingdom 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Acetic Acid
Location Trials
California 6
Texas 5
New York 4
Florida 3
New Jersey 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Acetic Acid

Clinical Trial Phase

Clinical Trial Phase for Acetic Acid
Clinical Trial Phase Trials
Phase 4 10
Phase 3 6
Phase 2/Phase 3 3
[disabled in preview] 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Acetic Acid
Clinical Trial Phase Trials
Completed 36
Unknown status 11
Recruiting 6
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Acetic Acid

Sponsor Name

Sponsor Name for Acetic Acid
Sponsor Trials
National Cancer Institute (NCI) 7
M.D. Anderson Cancer Center 4
Digna Biotech S.L. 3
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Acetic Acid
Sponsor Trials
Other 93
Industry 15
NIH 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Medtronic
AstraZeneca
Colorcon
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.